November 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreNovember 26, 2025
The U.S. behavioral health market is anticipated to grow from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 01, 2025
The simulators market size is projected to expand from USD 14.72 billion in 2026 to USD 25.53 billion by 2034,...
Read MoreNovember 01, 2025
Market insights predict the global scaffold technology industry will increase from USD 2.34 billion in 2024 to USD 8.58 billion by 2034, achieving a CAGR of 13.9%. North America led the market with a 41% share, while the Asia Pacific region is projected to experience the fastest growth throughout the forecast period. The hydrogels segment was ...
November 01, 2025
Market insights predict, the epinephrine industry is expected to grow from USD 3.11 billion in 2024 to USD 6.93 billion by 2034, driven by a CAGR of 8.34%. The increasing incidences of acute disorders like cardiovascular disorders, asthma, and allergic reactions; advanced healthcare infrastructure; and growing research & development activities ...
November 01, 2025
According to market estimations the global generic sterile injectable market was estimated at US$ 51.23 billion in 2025 and is projected to grow to US$ 82.14 billion by 2030. In 2023, North America led the market with a 40% share. Monoclonal antibodies dominated the market accounting for 34% of the share. The cancer therapeutic application held the...
November 01, 2025
According to market projections, the generic pharmaceuticals sector is expected to grow from USD 424.98 billion in 2024 to USD 947.67 billion by 2034, reflecting a CAGR of 8.35%. The rise in patent expiration, increasing demand for cost-effective and efficient medicines, and less complex approval process for generics drive the market growth. Generi...
November 01, 2025
According to market projections, the global hyperthermia cancer treatment market, valued at USD 198.44 million in 2024, is anticipated to reach USD 358.74 million by 2034, growing at a CAGR of 6.1% over the next decade. The rising incidences of cancer, growing research & development, and increasing investments drive the market....
November 01, 2025
The global recombinant human hair keratin protein market is rapidly growing, driven by demand for hair health solutions, wound healing, and biotech advancements. Key players and regions like North America, Asia-Pacific, and Europe are boosting R&D, investments, and collaborations, expanding market opportunities....
November 01, 2025
The anti-viral nasal spray market is projected to grow significantly from 2024 to 2034 due to rising viral infections, increasing immunity concerns and demand for needle-free, self-administered options. North America and Asia-Pacific lead the market, with children being the primary users....
November 01, 2025
According to market projections, the 7-Aminocephalosporanic Acid (7-ACA) market size to capture USD 715.1 million in 2025 and is to soar USD 981.59 million by 2030. The 7-Aminocephalosporanic Acid (7-ACA) market is growing due to the rising global demand for cephalosporin antibiotics, which are essential for treating infections like pneumonia, UTIs...
November 01, 2025
According to market projections, the global complement C4 antibody market, valued at USD 21.56 billion in 2024, is anticipated to reach USD 68.48 billion by 2034, growing at a CAGR of 12.25% over the next decade. The demand for complement C4 antibodies is growing in the market due to its various applications in disease diagnosis, immunology researc...
November 01, 2025
Market insights predict, the echinocandin B industry is expected to grow from USD 47.01 million in 2024 to USD 79.54 million by 2034, driven by a CAGR of 5.4%. The increasing incidences of fungal infections, growing research and development, and increasing investments drive the market....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com